✦ LIBER ✦

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab

✍ Scribed by Sastre, Javier; Vidaurreta, Marta; Gómez, Auxiliadora; Rivera, Fernando; Massutí, Bartomeu; López, Margarita Reboredo; Abad, Albert; Gallen, Manuel; Benavides, Manuel; Aranda, Enrique; Rubio, Eduardo Díaz

Book ID: 123589543
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 686 KB
Volume: 12
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2013.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of second-lin

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy

✍ Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh P 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB

Prognostic value ofKRASgenotype in metas

Prognostic value ofKRASgenotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

✍ Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 234 KB

Effectiveness of Liver Metastasectomies

Effectiveness of Liver Metastasectomies in Patients With Metastatic Colorectal Cancer Treated With FIr-B/FOx Triplet Chemotherapy Plus Bevacizumab

✍ Gemma Bruera; Katia Cannita; Felice Giuliante; Paola Lanfiuti Baldi; Roberto Vic 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 363 KB

6004 ORAL Role of Baseline Circulating T

6004 ORAL Role of Baseline Circulating Tumour Cells and KRas Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemotherapy Plus Bevacizumab: a TTD Spanish Group Cooperative Study

✍ Sastre, J.; Vidaurreta, M.; Gomez, A.; Rivera, F.; Valladares-Ayerbes, M.; Calle 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

3049 POSTER Management of hypertension (

3049 POSTER Management of hypertension (HTN) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV) plus chemotherapy (CT)

✍ M. Kozloff; J. Hainsworth; S. Badarinath; A. Cohn; P. Flynn; W. Dong; D. Purdie; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

KRAS as prognostic biomarker in metastat

KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials

✍ Petrelli, Fausto; Coinu, Andrea; Cabiddu, Mary; Ghilardi, Mara; Barni, Sandro 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 747 KB